Wegovy Pill's Record Launch Fuels $200bn Market Growth
The Wegovy pill's rapid US debut, with 50,000 weekly prescriptions, marks a pivotal shift in obesity treatment, driving big pharma's race to dominate a sector projected to hit $200bn by 2030.
The Wegovy pill's rapid US debut, with 50,000 weekly prescriptions, marks a pivotal shift in obesity treatment, driving big pharma's race to dominate a sector projected to hit $200bn by 2030.
Australian researchers have identified the mechanism behind rare blood clots from adenovirus vaccines like Johnson & Johnson's, offering a path to safer future immunisations.
Nestle has increased production to 24 hours a day at five European factories following a major global recall of infant formula products due to cereulide toxin contamination.
A BBC Breakfast guest tearfully described how his father lost £300,000 due to impulsive behaviour caused by Parkinson's medication, prompting calls for clearer drug warnings.
Shared lists with real-time sync. No signup needed — just open and shop together.
RecommendedA solicitor stole over £600,000 from elderly clients, spending it on sex and antiques, with his ex-wife attributing his actions to Parkinson's medication. The case led to both him and their son taking their own lives, highlighting the severe side effects
The MHRA warns men against buying unauthorised erectile dysfunction pills online after seizing 20 million illegal tablets, citing dangerous ingredients and exploitation of stigma.
The MHRA warns men to avoid buying unauthorised erectile dysfunction pills online after seizing nearly 20 million illegal tablets, many containing toxic or hidden ingredients.
UK regulators have intercepted nearly 20 million counterfeit erectile dysfunction pills since 2021, warning of health risks from online purchases. The MHRA highlights dangers including toxic ingredients and exploitation of stigma.
Multiple UK law firms are exploring legal claims against Pfizer on behalf of women who developed meningiomas after using the contraceptive injection Depo-Provera, citing studies showing increased risks.
Shared lists with real-time sync. No signup needed — just open and shop together.
RecommendedThe FDA has refused to consider Moderna's application for a new mRNA flu vaccine, citing issues with clinical trial design under Health Secretary Robert F. Kennedy Jr.'s leadership.
AstraZeneca's CEO Pascal Soriot calls the UK-US drug pricing agreement positive but says it won't revive a £200m Cambridge expansion, as the firm focuses on US and Chinese markets.
AstraZeneca reports a 40% surge in annual profits to $12.4 billion, driven by strong cancer drug sales and forecasts further growth with investments in weight-loss medications and expansion into the US and China.
Novo Nordisk has filed a patent infringement lawsuit against Hims & Hers Health after the telehealth firm launched a $49 copy of its weight-loss drug Wegovy, escalating the price war in the obesity medication market.
A new molecular glue degrader, NEO-811, is in clinical trials for kidney cancer, tricking cells into destroying harmful proteins, potentially reducing chemotherapy side effects.
Shared lists with real-time sync. No signup needed — just open and shop together.
RecommendedTelehealth firm Hims & Hers has abruptly cancelled its plan to sell a compounded version of Novo Nordisk's new Wegovy weight-loss pill, following FDA regulatory threats and legal pressure from the drugmaker.
The FDA has approved beetroot red food dye as part of a broader initiative to replace synthetic, petroleum-based colors linked to behavioral issues in children.
The White House has unveiled TrumpRx, a new government-run online portal for purchasing discounted prescription drugs, including popular GLP-1 weight-loss medications like Ozempic and Wegovy, with prices set to drop significantly.
Prescriptions for Novo Nordisk's new Wegovy weight-loss pill have surged, with weekly fills hitting 50,000 within weeks. Despite high demand, users report mixed results and the company warns of sales declines due to pricing pressures and competition.
Telehealth firm Hims & Hers launches cheaper compounded version of weight-loss pill Wegovy, prompting legal threats from Novo Nordisk over unapproved knockoff product.
Shared lists with real-time sync. No signup needed — just open and shop together.
RecommendedPfizer's experimental monthly weight loss injection demonstrated significant efficacy in a mid-stage trial, with participants losing up to 12.3% of body weight. The drug, acquired from Metsera, shows no plateau in weight loss after 28 weeks.
Online telehealth firm Hims & Hers Health introduces a compounded semaglutide pill at $49 monthly, undercutting Novo Nordisk's Wegovy by $150, sparking FDA warnings and a 6% share drop for Novo.
Akkarco LLC's Ashfiat Alharamain Energy Support supplement has been urgently recalled after FDA lab tests detected tadalafil, a prescription-strength erectile dysfunction drug, posing serious health risks.
Nestlé has updated its voluntary recall of several SMA baby formula products due to potential cereulide toxin contamination. Parents are urged to check batches and seek medical advice.
Telehealth firm Hims & Hers offers compounded semaglutide pills at $49 monthly, significantly cheaper than Novo Nordisk's Wegovy, sparking market reaction and regulatory scrutiny.
Shared lists with real-time sync. No signup needed — just open and shop together.
RecommendedUS health officials have issued a nationwide recall for Ashfiat Alharamain Energy Support after tests revealed undisclosed prescription-strength erectile dysfunction medication tadalafil in the honey-based supplement.
Scientists develop nasal spray delivering antibodies that neutralise influenza A and B viruses, offering potential short-term protection for healthcare workers during outbreaks.
A mother from Oxfordshire collapsed into a diabetic coma after injecting a counterfeit weight-loss pen purchased through social media, highlighting the dangers of unregulated online medication sales.
An experimental oral medication named enlicitide has demonstrated remarkable cholesterol-lowering effects in high-risk patients, potentially offering a convenient alternative to injections.
Danish pharmaceutical giant Novo Nordisk warns of an 8-13% sales decline for its weight-loss drugs Ozempic and Wegovy in 2026 due to unprecedented pricing pressures and rising competition from rivals like Eli Lilly.
Shared lists with real-time sync. No signup needed — just open and shop together.
RecommendedPfizer's experimental monthly weight loss injection, PF-08653944, demonstrated significant efficacy in a mid-stage trial, with participants losing up to 12.3% of body weight over 28 weeks.